NCAM1 and neoplasm: Detailed analysis of the mature CD56+CD94+LFA-1+ potentially cytotoxic NK cells indicated that cells developed in the presence of EZH1/2 inhibitors may display a slight decrease of CD107a+ cells upon incubation with tumor cell lines as compared to controls.